Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New series of metabotropic glutamate receptor antagonists designed at NPS

Jan. 23, 2001

Promising phase II results reported for Antegren in both MS and Crohn's disease

Jan. 23, 2001

Novel tachykinin NK1 receptor antagonists disclosed by Roche

Jan. 22, 2001

Biogen's Avonex meets primary endpoint in study of secondary progressive MS

Jan. 22, 2001

January launch for MyoBloc injectable solution for cervical dystonia

Jan. 22, 2001

Inhibitors of NOS and their therapeutic use claimed in recent patents by AstraZeneca

Jan. 19, 2001

New series of 5-HT7 antagonists designed by the former SB

Jan. 19, 2001

Novel combination therapies useful for weight gain associated with antipsychotic drugs

Jan. 19, 2001

Novel agents for epilepsy and other CNS disorders a focus of investigation at Pfizer

Jan. 18, 2001

Structurally novel series of 5-ht6 receptor antagonists evaluated for SAR

Jan. 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...